[CAS NO. 313526-24-8] IBR2
PRODUCTS SPECIFICATIONS [313526-24-8]
DESCRIPTION [313526-24-8]
Overview
| MDL | MFCD00991660 |
|---|---|
| Molecular Weight | 400.49 |
| Molecular Formula | C24H20N2O2S |
| SMILES | O=S(N1C(C2=CNC3=C2C=CC=C3)C4=C(C=CC=C4)C=C1)(CC5=CC=CC=C5)=O |
1 Publications Citing Use of MCE
Summary
IC50 & Target
RAD51 [1]
In Vitro
IBR2 shows interesting RAD51 inhibition activities. RAD51 is rapidly degraded in IBR2-treated cancer cells, and the homologous recombination repair is impaired, subsequently leading to cell death. The IC 50 values of the original IBR2 are in the range of 12-20 µM for most tested cancer cell lines. IBR2 can inhibit the growth of triple-negative human breast cancer cell line MBA-MD-468 with an IC 50 of 14.8 µM [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : ≥ 100 mg/mL ( 249.69 mM )
* "≥" means soluble, but saturation unknown.
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.4969 mL | 12.4847 mL | 24.9694 mL |
| 5 mM | 0.4994 mL | 2.4969 mL | 4.9939 mL |
| 10 mM | 0.2497 mL | 1.2485 mL | 2.4969 mL |
-
1.
References